Invesaro

Stocks Health care FTRE

NASDAQ · Health care

Fortrea Holdings Inc. (FTRE)

Fortrea Holdings Inc. brought in $2.7B of revenue over the twelve months to June 30, 2026, down 2.1% from a year earlier. It posted a net loss of $85.2M. Operating cash flow minus capital spending left $88.3M of free cash flow in fiscal 2025. At June 30, 2026 it held $168.6M in cash against $1.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.

Price
$19.89
-0.65% on the day · September 25, 2026
52-week range $8.31 to $21.39
Market cap
$1.9B
Revenue (last 12 months)
$2.7B
-2.1% year on year
Net margin
-3.2%

What Fortrea Holdings Inc. does

Fortrea Holdings Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker FTRE.

Revenue and profit by year

Revenue
FY21: $3.1B $3.1B FY21FY23: $2.8B $2.8B FY23FY23: $2.8B $2.8B FY23FY24: $2.7B $2.7B FY24FY25: $2.7B $2.7B FY25
Net income
FY21: $98M $98M FY21FY23: $186.2M $186.2M FY23FY23: -$25.2M -$25.2M FY23FY24: -$328.5M -$328.5M FY24FY25: -$986.2M -$986.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$2.7B-$872.6M-$986.2M-$10.81$88.3M
2024$2.7B-$161.9M-$328.5M-$3.67$237.3M
2023$2.8B$32M-$25.2M-$0.29$128.1M
2023$2.8B$187.1M$186.2M$2.09$28.3M
2021$3.1B$114.3M$98M$1.10$143.3M

Latest SEC filings

What Fortrea Holdings Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 10, 2026
    Executive or director change 8-K
  2. July 29, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. July 29, 2026
    Quarterly results 8-K
  4. July 14, 2026
    Executive or director change 8-K
  5. June 26, 2026
    Executive or director change 8-K
  6. June 12, 2026
    Shareholder vote results 8-K
  7. May 5, 2026
    Quarterly report 10-Q · period to March 31, 2026
  8. May 5, 2026
    Quarterly results 8-K
  9. April 29, 2026
    Passive stake (5% or more) SCHEDULE 13G
  10. April 27, 2026
    Annual report to shareholders ARS

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 14, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about FTRE

What does Fortrea Holdings Inc. do?

Fortrea Holdings Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker FTRE.

Is Fortrea Holdings Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $85.2M on revenue of $2.7B.

How much revenue does Fortrea Holdings Inc. make?

Over the twelve months to June 30, 2026 Fortrea Holdings Inc. reported revenue of $2.7B. That is 2.1% less than a year earlier.

When did Fortrea Holdings Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 14, 2026.

Similar companies

LH
Labcorp Holdings Inc.
DGX
Quest Diagnostics Inc
NTRA
Natera, Inc.
RDNT
RadNet, Inc.
GH
Guardant Health, Inc.
CAI
Caris Life Sciences, Inc.

Follow FTRE

Get an email when Fortrea Holdings Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow FTRE: get an email when it files

Where the numbers come from

Financial figures are the values Fortrea Holdings Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.